Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance

Luca Triggiani, Rosario Mazzola, Davide Tomasini, Alessio Bruni, Giulia Alicino, Fabio Matrone, Roberto Bortolus, Giulio Francolini, Beatrice Detti, Alessandro Magli, Marco Lorenzo Bonù, Gianluca Ingrosso, Andrea Lancia, Fabio Trippa, Ernesto Maranzano, Ciro Franzese, Paolo Ghirardelli, Vittorio Vavassori, Marta Scorsetti, Filippo AlongiStefano Maria Magrini

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance'. Together they form a unique fingerprint.

Medicine & Life Sciences